Omega Healthcare Investors Q3 2026 earnings
Strong quarter with record investment activity and leverage reduction, driving a 6.3% year-over-year increase in FAD per share.
Headline numbers
| Metric | Actual | YoY | QoQ | 8-K location |
|---|---|---|---|---|
| EPS (GAAP) | $0.27 | +54.2% | -77.0% | Ex. 99.1, income statement |
| EPS (adjusted) | $0.81 | +3.8% | -69.0% | Ex. 99.1, income statement |
| Adj. EBITDA | $262.1M | +8.0% | +0.2% | Ex. 99.1, income statement |
| Adj. EBITDA margin | 77.0% | +1.2 pp | +0.1 pp | Ex. 99.1, income statement |
Revenue breakdown
not stated in the 8-K
Margins and costs
- Gross margin 77.0% (prior 75.8%, change +1.2 pp)
- Operating expenses $263.8M (+58.4% YoY)
- One-offs in the quarter Impairment on real estate properties $11.4M; Acquisition, merger and transition related costs $59.9M; Severance expense $18.8M; Loss on debt extinguishment $0.0M
- Effective tax rate 3.3% (prior-year 2.3%, year-to-date 2.0%)
- Non-GAAP bridge Adds back acquisition, merger and transition related costs, severance expense, stock-based compensation, straight-line rent and other write-offs, loss on debt extinguishment, non-cash (recovery) provision for credit losses, and other normalizing items.
KPIs
| Metric | Actual | Prior quarter | Prior year | Change |
|---|---|---|---|---|
| FAD per share | $0.78 | $0.82 | $0.73 | +6.8% YoY |
| Total investments (YTD) | $1.5B | $1.26B | $1.09B | +38.5% YoY |
| Total investments (Q3) | $1.67B | $0.11B | $0.10B | +1,570% YoY |
| Total debt | $4.02B | $4.02B | $4.01B | +0.2% YoY |
| Debt to capitalization | 41.2% | 41.4% | 41.3% | -0.2 pp YoY |
Guidance
| Metric | Guide | Prior guide | Change |
|---|---|---|---|
| AFFO per share | $3.29 | $3.24 | +5 cents |
| Total investments (full year) | $1.5B | $1.3B | +$200M |
What drove it
- Revenue story Total revenues increased 9.3% year-over-year, driven by a 3.2% decrease in rental income partially offset by increases in real estate loans interest income (+0.8%), non-real estate loans interest income (-26.1%), and resident fees and services (+1,425%).
- EPS story The increase in adjusted EPS came primarily from higher adjusted funds from operations (AFFO) and a lower share count.
- One-off check Impairment on real estate properties $11.4M; Acquisition, merger and transition related costs $59.9M; Severance expense $18.8M; Loss on debt extinguishment $0.0M.
The good
- FAD per share increased 6.3% year-over-year
- Total investments year-to-date reached $1.5 billion
- Debt to capitalization reduced to 41.2%, the lowest in the Company's history
- AFFO guidance increased by 5 cents to $3.29
The bad
- Net income and GAAP EPS declined significantly quarter-over-quarter due to a $249.1M loss on asset sales
- Rental income decreased 3.1% year-over-year
The ugly
- none
Open questions
- The release does not provide a reconciliation of the $1.5 billion total investments figure to the specific components (acquisitions, loans, unconsolidated entities) for the full year.
- The release does not provide a reconciliation of the $1.5 billion total investments figure to the specific components (acquisitions, loans, unconsolidated entities) for the full year.
Full release
Omega Healthcare Investors (OHI) earnings release, November 3, 2026
PRESS RELEASE – FOR IMMEDIATE RELEASE
OMEGA REPORTS THIRD QUARTER 2026 RESULTS
AND RECENT DEVELOPMENTS
Completed $1.5 Billion in New Investments Year-to-Date, Including $946 Million Since Quarter-End
Raises Full Year 2026 Guidance
HUNT VALLEY, MARYLAND – November 3, 2026 – Omega Healthcare Investors, Inc. (NYSE: OHI) (the “Company” or “Omega”) announced today its results for the quarter ended September 30, 2026.
THIRD QUARTER 2026 AND RECENT HIGHLIGHTS
Nareit Funds From Operations (“Nareit FFO”), AFFO, FAD and NOI are supplemental non-GAAP financial measures the Company believes are useful in evaluating the performance of real estate investment trusts (“REITs”). Reconciliations and further information regarding these non-GAAP measures are provided at the end of this press release.
CEO COMMENTS
Matthew Gourmand, Omega’s Chief Executive Officer, stated, “We are pleased to report strong third quarter results, as we continued to grow FAD per share year over year, while reducing leverage to the lowest level in the Company’s history. As a result, we were again able to increase our AFFO guidance, moving the midpoint up by five cents to $3.29.”
Mr. Gourmand continued, “The investments made in the third and early fourth quarter highlight the breadth of opportunities available to us to continue to grow shareholder value. The pipeline remains strong, and we expect to make further accretive investments through the remainder of this year and into early 2027.”
Mr. Gourmand concluded, “Importantly, the backdrop that has allowed us to deliver strong shareholder returns over the past few years remains in place. Operating metrics continue to be robust, with operator coverage further improving in the quarter, and we have a strong balance sheet and cost of capital that should allow us to continue to accretively invest.”
THIRD QUARTER 2026 PORTFOLIO AND RECENT ACTIVITY
Operator Updates:
PACS – On October 1, 2026, the Company transitioned 32 SNFs in Florida from Airamid Health Services, LLC (“Airamid”) to PACS and added the facilities to the Company’s existing PACS master lease. Initial annual contractual rent attributable to the facilities is $58.0 million, an increase of $26.1 million from the prior annual contractual rent on the portfolio. Annual contractual rent increases by an additional $2.5 million in year two, with 2% annual escalators thereafter through the lease’s January 31, 2038 maturity. The Company also paid Airamid a $90.0 million lease termination fee in connection with the transition, which was capitalized and will be amortized over the remaining term of the PACS lease.
Genesis – In October 2026, the Genesis Chapter 11 bankruptcy sale was finalized, resulting in the assumption and assignment of Omega’s master lease to affiliates of 101 W State Street Holdings, LLC (“NewGen”). In connection with the bankruptcy finalization, Omega received $149.5 million during October 2026 related to repayments of amounts outstanding under its DIP and term loans. During the third quarter of 2026, Omega recognized $13.3 million of rental income and $4.8 million of interest income related to Genesis.
Maplewood – In the third quarter of 2026, Maplewood Senior Living (along with affiliates “Maplewood”) paid $20.1 million in rent (compared to $19.6 million in the second quarter of 2026).
New Investments:
The following table presents investment activity:
$167 Million in Real Estate Acquisitions – In the third quarter of 2026, the Company acquired 17 facilities for $167.3 million, comprised of:
$14 Million in Real Estate Loans – In the third quarter of 2026, the Company funded $14.2 million in real estate loans, including $12.8 million (CAD 18.0 million) of additional funding under a previously disclosed Canadian development loan.
$946 Million in Q4 2026 Investment Activity – From October 1, 2026 through the date of this release, the Company completed $945.5 million of new investments, comprised of:
Other Portfolio Activity:
$48 Million in U.K. RIDEA Conversions – During the third quarter of 2026, the Company acquired the operators of 30 U.K. care homes for £35.8 million ($48.0 million) in cash and converted the facilities from triple-net leases to RIDEA structures, which will be managed by three established U.K. operators with whom the Company has existing relationships. Annual contractual rent associated with the 30 U.K. care homes prior to the conversion was £20.1 million ($26.7 million) with an EBITDAR coverage ratio of 1.47x for the trailing twelve months ended June 30, 2026. Substantially all of the purchase consideration represented payments to terminate the Company’s preexisting leases with the operators. These amounts, together with related transaction expenses, were recorded as acquisition, merger and transition related costs.
Saber PropCo JV – $88 Million in Real Estate Investments – In July 2026, SHH Holdings, LLC (“Saber PropCo JV”), a property holding company in which Omega owns a 49% equity interest, completed the acquisition of five SNFs for $87.7 million as part of the Ciena Laurels portfolio transactions previously disclosed in the second quarter of 2026. As of September 30, 2026, Saber PropCo JV owned 71 facilities leased to Saber Healthcare Holdings, LLC under triple-net leases generating annual contractual rent of $83.1 million and had $584.4 million of mortgage debt outstanding with a weighted-average interest rate of 5.2%.
Held for Sale and Impairments:
Held for Sale – At September 30, 2026, one care home with a net book value of $1.3 million was classified as held for sale.
Impairments – In the third quarter of 2026, the Company recorded an $11.4 million net impairment charge related to one facility.
TRIPLE-NET AND MORTGAGE LOAN OPERATOR COVERAGE DATA... (truncated)erified this information and is providing this data for informational purposes only. The data excludes non-core facilities, as defined in the Third Quarter 2026 Quarterly Supplement available under “Financial Info” in the Investors section of Omega’s website.
FINANCING ACTIVITIES
ATM Program and Dividend Reinvestment and Common Stock Purchase Plan – The following is a summary of the common shares issued through the third quarter of 2026:
Financial statements
Income Statement
Three Months Ended — (in thousands, except per share amounts)
| Three Months Ended – September 30, – 2026 | Three Months Ended – September 30, – 2025 | Nine Months Ended – September 30, – 2026 | Nine Months Ended – September 30, – 2025 | |
|---|---|---|---|---|
| Revenues | ||||
| Rental income | 252,800 | 260,744 | 782,394 | 724,715 |
| Real estate tax and ground lease income | 4,185 | 3,796 | 11,694 | 11,205 |
| Real estate loans interest income | 34,190 | 34,421 | 102,479 | 100,558 |
| Non-real estate loans interest income | 7,662 | 10,390 | 31,284 | 30,366 |
| Resident fees and services | 30,756 | 51,400 | ||
| Miscellaneous income | 10,961 | 2,240 | 12,504 | 4,038 |
| Total revenues | 340,554 | 311,591 | 991,755 | 870,882 |
| Expenses | ||||
| Depreciation and amortization | 82,033 | 82,114 | 248,015 | 242,498 |
| Interest expense | 44,539 | 58,115 | 142,410 | 163,292 |
| Property-level expenses(1) | 29,937 | 4,019 | 55,577 | 11,616 |
| General and administrative | 14,241 | 13,985 | 43,620 | 41,390 |
| Stock-based compensation expense | 6,564 | 9,277 | 25,898 | 27,721 |
| Severance expense | 18,751 | 37,622 | 9,011 | |
| Acquisition, merger and transition related costs | 59,879 | 593 | 65,653 | 4,067 |
| Impairment on real estate properties | 11,355 | 1,144 | 11,747 | 16,594 |
| Recovery for credit losses | -3,509 | -3,908 | -11,822 | -3,587 |
| Total expenses | 263,790 | 165,339 | 618,720 | 512,602 |
| Other income (expense) | ||||
| Other income – net | 9,085 | 16,835 | 2,946 | 33,633 |
| Loss on debt extinguishment | -7 | -7 | ||
| (Loss) gain on assets sold – net | -434 | 28,269 | 249,109 | 61,230 |
| Total other income | 8,651 | 45,097 | 252,055 | 94,856 |
| Income before income tax expense and income (loss) from unconsolidated entities | 85,415 | 191,349 | 625,090 | 453,136 |
| Income tax expense | -2,836 | -4,483 | -12,560 | -12,622 |
| Income (loss) from unconsolidated entities | 4,236 | -1,910 | 12,529 | -3,019 |
| Net income | 86,815 | 184,956 | 625,059 | 437,495 |
| Net income attributable to noncontrolling interest | -3,723 | -5,237 | -28,095 | -12,145 |
| Net income available to common stockholders | 83,092 | 179,719 | 596,964 | 425,350 |
| Basic: | ||||
| Net income available to common stockholders | 0.27 | 0.6 | 1.94 | 1.41 |
| Diluted: | ||||
| Net income available to common stockholders | 0.27 | 0.59 | 1.92 | 1.39 |
| Dividends declared per common share | 0.68 | 0.67 | 2.02 | 2.01 |
Income Statement
Three Months Ended — (in thousands, except per share amounts)
| Three Months Ended – September 30, – 2026 | Three Months Ended – September 30, – 2025 | Nine Months Ended – September 30, – 2026 | Nine Months Ended – September 30, – 2025 | |
|---|---|---|---|---|
| Net income (1) | 86,815 | 184,956 | 625,059 | 437,495 |
| Add back loss (deduct gain) from real estate dispositions | 434 | -28,269 | -249,109 | -61,230 |
| Sub-total | 87,249 | 156,687 | 375,950 | 376,265 |
| Elimination of non-cash items included in net income: | ||||
| Depreciation and amortization | 82,033 | 82,114 | 248,015 | 242,498 |
| Depreciation – unconsolidated entities | 10,838 | 1,865 | 29,222 | 3,704 |
| Impairment on real estate properties | 11,355 | 1,144 | 11,747 | 16,594 |
| Nareit funds from operations (“Nareit FFO”) | 191,475 | 241,810 | 664,934 | 639,061 |
| Weighted-average common shares outstanding, basic | 303,877 | 295,827 | 299,949 | 290,057 |
| Restricted stock and PRSUs | 2,987 | 3,485 | 3,138 | 3,561 |
| Omega OP Units | 14,150 | 8,861 | 14,398 | 8,547 |
| Weighted-average common shares outstanding, diluted | 321,014 | 308,173 | 317,485 | 302,165 |
| Nareit funds from operations available per share | 0.6 | 0.78 | 2.09 | 2.11 |
| Adjustments to calculate adjusted funds from operations | ||||
| Nareit FFO | 191,475 | 241,810 | 664,934 | 639,061 |
| Add back (deduct): | ||||
| Acquisition, merger and transition related costs | 59,879 | 593 | 65,653 | 4,067 |
| Severance expense | 18,751 | 37,622 | 9,011 | |
| Stock-based compensation expense | 6,564 | 9,277 | 25,898 | 27,721 |
| Straight-line rent and other write-offs (2) | 4,858 | 14,620 | 27,537 | |
| Loss on debt extinguishment | 7 | 7 | ||
| Non-cash (recovery) provision for credit losses | -1,020 | -2,570 | -4,851 | 1,578 |
| Other normalizing items – net (3) | -18,413 | -6,349 | -20,752 | -12,593 |
| Adjusted funds from operations (“AFFO”) (1)(4) | 262,094 | 242,768 | 783,124 | 696,389 |
| Adjustments to calculate funds available for distribution | ||||
| Non-cash expense (5) | 1,119 | 1,684 | 3,745 | 7,621 |
| Capitalized interest | -190 | -98 | -470 | -929 |
| Non-cash revenue | -13,291 | -13,143 | -42,336 | -37,803 |
| Funds available for distribution (“FAD”) (1)(4) | 249,732 | 231,211 | 744,063 | 665,278 |
Income Statement
Three Months Ended September 30, — (in thousands)
| Three Months Ended September 30, – 2026 | Three Months Ended September 30, – 2025 | Nine Months Ended September 30, – 2026 | Nine Months Ended September 30, – 2025 | |
|---|---|---|---|---|
| Net income | 86,815 | 184,956 | 625,059 | 437,495 |
Balance Sheet
September 30, — (in thousands, except per share amounts)
| September 30, – 2026 – (Unaudited) | December 31, – 2025 | |
|---|---|---|
| Real estate assets | ||
| Buildings and improvements | 7,866,193 | 7,901,652 |
| Land | 1,196,222 | 1,179,463 |
| Furniture and equipment | 542,504 | 539,775 |
| Construction in progress | 21,071 | 12,492 |
| Total real estate assets | 9,625,990 | 9,633,382 |
| Less accumulated depreciation | -3,061,110 | -2,930,611 |
| Real estate assets – net | 6,564,880 | 6,702,771 |
| Real estate loans receivable – net | 1,345,599 | 1,380,949 |
| Investments in unconsolidated entities | 494,764 | 414,127 |
| Assets held for sale | 1,297 | 4,000 |
| Total real estate investments | 8,406,540 | 8,501,847 |
| Non-real estate loans receivable – net | 254,537 | 330,322 |
| Total investments | 8,661,077 | 8,832,169 |
| Cash and cash equivalents | 195,897 | 27,024 |
| Restricted cash | 27,708 | 27,539 |
| Contractual and other receivables – net | 275,191 | 280,774 |
| Goodwill | 648,550 | 644,626 |
| Other assets | 312,850 | 236,927 |
| Total assets | 10,121,273 | 10,049,059 |
| LIABILITIES AND EQUITY | ||
| Revolving credit facility | $— | 242,000 |
| Senior notes and other unsecured borrowings – net | 4,020,927 | 4,014,011 |
| Accrued expenses and other liabilities | 337,279 | 352,549 |
| Total liabilities | 4,358,206 | 4,608,560 |
| Common stock $0.10 par value authorized – 700,000 shares, issued and outstanding – 303,854 shares as of September 30, 2026 and 295,539 shares as of December 31, 2025 | 30,385 | 29,553 |
| Additional paid-in capital | 9,047,164 | 8,693,033 |
| Cumulative net earnings | 5,274,056 | 4,677,092 |
| Cumulative dividends paid | -8,903,042 | -8,297,416 |
| Accumulated other comprehensive income | 57,527 | 79,037 |
| Total stockholders’ equity | 5,506,090 | 5,181,299 |
| Noncontrolling interest | 256,977 | 259,200 |
| Total equity | 5,763,067 | 5,440,499 |
| Total liabilities and equity | 10,121,273 | 10,049,059 |
Cash Flow
From the 10-Q · Nine Months Ended September 30, — (in thousands)
| Nine Months Ended September 30, – 2026 | Nine Months Ended September 30, – 2025 | |
|---|---|---|
| Cash flows from operating activities | ||
| Net income | 625,059 | 437,495 |
| Adjustment to reconcile net income to net cash provided by operating activities: | ||
| Depreciation and amortization | 248,015 | 242,498 |
| Impairment on real estate properties | 11,747 | 16,594 |
| Straight-line rent and other write-offs | 25,822 | 27,537 |
| (Recovery) provision for credit losses | -11,822 | -3,587 |
| Amortization of deferred financing costs and loss on debt extinguishment | 10,212 | 3,458 |
| Stock-based compensation expense | 57,737 | 34,323 |